For instance, the overexpression of LHX2 promotes the development of chronic myeloid leukemia [26], pancreatic ductal carcinoma [27], nasopharyngeal carcinoma [28], and non-small-cell lung cancer [29]. This evidence concerns the gene LHX2 and chronic myelogenous leukemia, BCR-ABL1 positive.